LQDA Liquidia Earnings and EPS analysis

Relative Growth: Rel. Growth: 97

Relative Strength: Rel. Strength: 94

Relative Valuation: Rel. Valuation: 14

Relative Profitability: Rel. Profitability: 98

EPS in 2026 (TTM): $0.24

Last Report Period Date: Mar 31, 2026

According to the most recent financial data from March 2026, the current EPS (TTM) is $0.24. Liquidia's EPS for 2025 came in at -$0.8, marking an increase from -$1.63 in 2024. For the quarterly period ending on Mar 31, 2026, LQDA's EPS was $0.6.

LQDA earnings history

Historical annual and quarterly earnings per share (EPS) data for Liquidia

EPS (TTM)

$0.24

EPS Growth YoY (Quarterly)

233.3%

EPS (Quarterly)

$0.6

EPS Growth (Quarterly)

252.9%

Liquidia had an annual EPS of -$0.8, marking an increase of 50.9% from -$1.63 in 2024. The quarterly EPS for the period ending Mar 31, 2026, was $0.6, marking a 233.3% increase from the same quarter last year. LQDA's TTM EPS stands at $0.24 as of March 2026. Liquidia's EPS for 2024 stood at -$1.63, a 34.7% decrease from 2023.

LQDA earnings chart

LQDA EPS growth history

Earnings per share growth rates over time

EPS Growth YoY (Quarterly)

233.3%

EPS growth YoY

50.9%

EPS growth 3Y avg

N/A

EPS growth 5Y avg

N/A

Liquidia has recorded an increase in EPS of 233.3% over the last 12 months (YoY, quarterly).

LQDA Earnings Waterfall

Breakdown of revenue, profit and net income for Liquidia

LQDA Earnings vs Peers

What are the earnings of LQDA compared to its peers

Stock name	Price to Earnings	EPS grwoth 1Y	EPS grwoth 3Y	EPS grwoth 5Y
VIVS VivoSim Labs Inc.	0.77	91.2%	N/A	N/A
ORMP Oramed Pharmaceuticals Inc	1.44	418.8%	N/A	N/A
OMER Omeros Corp	7.88	98.1%	N/A	N/A
LQDA Liquidia Corp	260.5	50.9%	N/A	N/A
OLMA Olema Pharmaceuticals Inc	N/A	15%	N/A	N/A
ORIC Oric Pharmaceuticals Inc	N/A	19.7%	N/A	N/A

All data is based on quarterly TTM periods, unless otherwise specified.